A proposal of post-operative nomogram for overall survival in patients with renal cell carcinoma and venous tumor thrombus

被引:26
作者
Gu, Liangyou [1 ]
Wang, Zihuan [2 ]
Chen, Luyao [1 ]
Ma, Xin [1 ]
Li, Hongzhao [1 ]
Nie, Wenyuan [1 ]
Peng, Cheng [1 ]
Li, Xintao [1 ]
Gao, Yu [1 ]
Zhang, Xu [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, PLA Med Sch, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China
[2] Beijing Ctr Dis Control & Prevent, Inst Occupat Hlth, Beijing, Peoples R China
关键词
biomarker; nomogram; prognosis; renal cell carcinoma; thrombus; INFERIOR VENA-CAVA; COLLECTING SYSTEM INVASION; CANCER-SPECIFIC SURVIVAL; SINGLE-CENTER EXPERIENCE; SURGICAL-MANAGEMENT; THROMBECTOMY; NEPHRECTOMY; INVOLVEMENT; IMPACT; STRATIFICATION;
D O I
10.1002/jso.24575
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVETo identify the predictors of overall survival (OS) and create a post-operative prognostic model for patients with renal cell carcinoma (RCC) and venous tumor thrombus (VTT). PATIENTS AND METHODSThe study cohort included patients with RCC and VTT that underwent full surgical resection between 2006 and 2016. Univariate and multivariate analyses were used to determine the prognostic factors of OS. A nomogram was developed and internally calibrated by bootstrap resampling method. RESULTSA total of 185 patients were identified, including patients with thrombus present in the renal vein (109 patients, 58.9%), infrahepatic inferior vena cava (IVC; 68 patients, 36.8%), and suprahepatic IVC (8 patients, 4.3%). After a median follow-up of 30.2 months (interquartile range, 12.1-48.4 months), 63 (34.1%) patients died. Independent prognostic factors for OS included histological subtype, collecting system invasion, metastasis at surgery, De Ritis ratio (AST/ALT), and serum albumin. Independently predictive variables were used to create a nomogram, which achieved a concordance index of 0.75 for OS. CONCLUSIONSFor patients with RCC and VTT, the developed and internally validated post-operative nomogram can be used to select patients who may benefit from aggressive surveillance regimens or adjuvant therapy clinical trials.
引用
收藏
页码:905 / 912
页数:8
相关论文
共 50 条
[21]   Clinical management of renal cell carcinoma with venous tumor thrombus [J].
Agochukwu, Nnenaya ;
Shuch, Brian .
WORLD JOURNAL OF UROLOGY, 2014, 32 (03) :581-589
[22]   Immunogenic Heterogeneity of Renal Cell Carcinoma With Venous Tumor Thrombus [J].
Liss, Michael A. ;
Chen, Yidong ;
Rodrigue, Ronald ;
Pruthi, Deepak ;
Johnson-Pais, Teresa ;
Wang, Hanzhang ;
Mansour, Ahmed ;
Kaushik, Dharam .
UROLOGY, 2019, 124 :168-173
[23]   Growth kinetics of venous tumor thrombus in patients with renal cell carcinoma [J].
Barashi, Nimrod S. ;
Friedman, Daniel ;
Shiang, Alex ;
Pickersgill, Nicholas ;
Vetter, Joel ;
Suresh, Tara ;
Ippolito, Joseph E. ;
Smith, Zachary L. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (02) :31e17-31e23
[24]   The role of transesophageal echocardiography in the management of renal cell carcinoma with venous tumor thrombus [J].
Calderone, Carli E. ;
Tuck, Benjamin C. ;
Gray, Stephen H. ;
Porter, Kristin K. ;
Rais-Bahrami, Soroush .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2018, 35 (12) :2047-2055
[25]   Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC) [J].
Weiss, Valerie L. ;
Braun, Martin ;
Perner, Sven ;
Harz, Andreas ;
Vorreuther, Roland ;
Kristiansen, Glen ;
Mueller, Stefan C. ;
Ellinger, Joerg .
BJU INTERNATIONAL, 2014, 113 (02) :209-217
[26]   Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience [J].
Chen, Xiaonan ;
Li, Shijie ;
Xu, Zhenqun ;
Wang, Kefeng ;
Fu, Donghui ;
Liu, Qiang ;
Wang, Xia ;
Wu, Bin .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
[27]   Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus [J].
Watanabe, Shun ;
Ishihara, Hiroki ;
Takagi, Toshio ;
Kondo, Tsunenori ;
Ishiyama, Ryo ;
Fukuda, Hironori ;
Yoshida, Kazuhiko ;
Iizuka, Junpei ;
Kobayashi, Hirohito ;
Ishida, Hideki ;
Tanabe, Kazunari .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) :819-825
[28]   The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus [J].
Ihaddadene, R. ;
Yokom, D. W. ;
Le Gal, G. ;
Moretto, P. ;
Canil, C. M. ;
Delluc, A. ;
Reaume, N. ;
Carrier, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (06) :855-859
[29]   Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma [J].
Wenwen Zheng ;
Weiwei Zhu ;
Shengqiang Yu ;
Kangqi Li ;
Yuexia Ding ;
Qingna Wu ;
Qiling Tang ;
Quan Zhao ;
Congxiao Lu ;
Chenyu Guo .
BMC Cancer, 20
[30]   Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma [J].
Zheng, Wenwen ;
Zhu, Weiwei ;
Yu, Shengqiang ;
Li, Kangqi ;
Ding, Yuexia ;
Wu, Qingna ;
Tang, Qiling ;
Zhao, Quan ;
Lu, Congxiao ;
Guo, Chenyu .
BMC CANCER, 2020, 20 (01)